揭示Verbascum aydogdui的抗癌潜力:隔离,表征和体外研究
Şerife Sena Günaydın1, Anita Barta2,3, Ayşe Nur Çaldıran4
1Department of Pharmacognosy, Faculty of Pharmacy, Yeditepe University, İstanbul, Türkiye.
Chemistry & biodiversity
|January 8, 2026
概括
这项研究从Verbascum aydogdui中分离出16种化合物,其中两种三烯酸盐 (ilwensisaponin A和buddlejasaponin I) 显示出显著的抗癌活性. 伊尔文西沙尼A在各种癌细胞系中有效诱导了亡,突出了其作为天然抗癌剂的潜力.
科学领域:
- 自然产品化学 自然产品化学
- 药理学 药理学是指药理学的学科.
- 药用植物研究 药用植物研究
背景情况:
- 一种土耳其特有植物Verbascum aydogdui的生物活性或植物化学特征以前没有被研究过.
- 自然产品是潜在的抗癌剂的丰富来源.
研究的目的:
- 从Verbascum aydogdui中分离和识别二次代谢物.
- 评估与各种人类癌症细胞系对抗分离化合物的细胞毒性活性.
- 研究最强大的细胞毒性化合物的作用机制.
主要方法:
- 在细胞毒性指导下分化Verbascum aydogdui的乙醇提取物.
- 16种二次代谢物的隔离和结构阐明 (8种三三酸盐酸,6种化糖化物,2种化糖化物).
- 在实验室中对PC3,HEPG2,HGC27,A375,MCF7和SW480癌细胞系进行细胞毒性测定.
- 亡和亡测定,包括p53和p21表达分析.
主要成果:
- 他们分离了16种化合物,包括8种三二烯沙波宁,6种化糖化物和2种化糖化物.
- 化合物1-5表现出显著的细胞毒性,其中ilwensisaponin A (2) 和buddlejasaponin I (3) 是最强的.
- 伊尔文西沙尼A (2) 显示出广泛的抗癌作用,主要是通过通过对p53和p21的上调来诱导亡.
结论:
- 这是关于Verbascum aydogdui的生物活性和植物化学成分的第一份报告.
- 伊尔文西沙尼A (2) 显示出作为一种天然抗癌产品的显著潜力.
- 进一步的体外和体内研究是有必要的,以探索ilwensisaponin A.的治疗潜力.
关键词:
这就是为什么Verbascum Aydogdui.灭症 (apoptosis) 是一种死亡的过程.细胞毒性活动的细胞毒性.死亡死亡的死亡.三二烯的三二烯的三二烯的三二烯的三二烯的三二烯的三二烯的三二烯的三二烯的三二烯的三二烯的三二烯的三二烯的三二烯的三二烯的三二烯的三二烯.更多相关视频
09:20Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
Published on: June 26, 2018
8.8K
09:03Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula
Published on: January 26, 2024
661
相关概念视频
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Drugs that Stabilize Microtubules
2.6K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.6K
Inhibition of Cdk Activity
5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
